Virucidal activity of Povidone-Iodine against SARS-CoV-2 |
Molecule Updates
eMediNexus Coverage from: 
Virucidal activity of Povidone-Iodine against SARS-CoV-2

1 Read Comments                

It is now well known that the severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2 is transmitted through respiratory droplets and physical contact from contaminated surfaces to the mucosa. Among various measures to prevent the spread of this virus, hand hygiene and oral decontamination play a key role. The researchers thus evaluated the in vitro virucidal activity of topical and oral Povidone-Iodine (PVP-I) products against SARS-CoV-2.Four PVP-I products [BETADINE antiseptic solution (PVP-I 10% w/v), BETADINE antiseptic skin cleanser (PVP-I 7.5% w/v), BETADINE Gargle and mouth wash (PVP-I 1.0% w/v) and BETADINEthroat spray (PVP-I 0.45% w/v)] were tested at the Animal Biosafety Level (ABSL) 3 facility in Singapore. They used suspension assays to assess the virucidal activity of PVP-I against SARS-CoV-2. Products were tested at a contact time of 30 s for virucidal activity. Viral ...
To Read or comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now